Sanofi SNY announced that it has entered into an agreement to acquire privately-held, immuno-oncology company, Amunix Pharmaceuticals, for an upfront payment of approximately $1 billion. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results